Roche announce new Phase II clinical trial

Following the disappointing news in March last year that Roche’s highly anticipated drug trial for the HD drug tominersen would be abandoned, we’ve had a more promising start to 2022! Roche has just announced that they will be starting a new Phase II clinical trial into the drug, which they say appears to have some […]